Public-registry site landscape for NCT05002270, a Advanced Solid Tumor study sponsored by Jacobio Pharmaceuticals Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05002270 (registry record) |
| Sponsor | Jacobio Pharmaceuticals Co., Ltd. |
| Condition(s) | Advanced Solid Tumor; NSCLC; CRC |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 4 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05002270 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →